Background
Allergy-related studies that include biological measurements of vitamin D preceding well-measured outcomes are needed.
Objective
Examine the associations between early life vitamin D levels and the development of allergy-related outcomes in the racially diverse WHEALS birth cohort.
Methods
25-hydroxyvitamin D [25(OH)D] was measured in stored blood samples from pregnancy, cord blood and age 2 years. Logistic regression models were used to calculate odds ratios (OR) with 95% confidence intervals (CI) for a 5 ng/ml increase in 25(OH)D level for the outcomes at age 2 years: eczema, skin prick tests (SPT), elevated allergen-specific IgE (sIgE≥0.35IU/ml), and doctor diagnosis of asthma (3–6 years).
Results
Prenatal 25(OH)D was inversely associated with eczema (OR=0.85, 95% CI 0.75, 0.96). The association was stronger in White children (White: OR=0.79, 95% CI 0.57, 1.09; Black: OR=0.96, 95% CI 0.82, 1.12), although this was not statistically significant. Cord blood 25(OH)D was inversely associated with having ≥1 positive SPT and aeroallergen sensitization. Both associations were statistically significant in White children (SPT: OR=0.50, 95% CI 0.32, 0.80; ≥1 aeroallergen: OR=0.50, 95% CI 0.28, 0.92) in contrast with Black children (SPT:OR=0.88, 95% CI 0.68, 1.14; aeroallergen: OR=0.85, 95% CI 0.65, 1.11). 25(OH)D measured concurrent with outcome assessment was inversely associated with aeroallergen sensitization (OR=0.79, 95% CI 0.66, 0.96) only among Black children (White children: OR=1.21, 95% CI 0.87, 1.69).
Conclusions
Prenatal and cord 25(OH)D were associated with some allergy-related outcomes with a general pattern indicating that children with higher 25(OH)D tend to have fewer allergy-related outcomes.